Amphastar Nanjing Pharmaceuticals, Inc.

FDA Regulatory Profile

Amphastar Nanjing Pharmaceuticals, Inc. has 0 FDA recalls, 5 inspections, 1 510(k) clearance and 0 compliance actions on record.

Latest inspection
Mar 7, 2025 · NAI
Latest 510(k)
Feb 12, 2021

Reviewing Amphastar Nanjing Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Request a free FDA snapshot

Or get Amphastar Nanjing Pharmaceuticals, Inc.'s full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Oct 23, 2026Not statedCurrent
510(k) clearances1Oct 4, 2026Not statedCurrent
Inspections5Oct 26, 2026Not statedCurrent
Compliance actions0Oct 23, 2026Not statedCurrent

Recent FDA Inspections

DateSiteProductClassificationFEI
Mar 7, 2025Nanjing, ChinaDrugsNo Action Indicated (NAI)3009805706
Oct 11, 2019Nanjing, ChinaDrugsVoluntary Action Indicated (VAI)3009805706
Oct 26, 2017Nanjing, ChinaDrugsNo Action Indicated (NAI)3009805706
Apr 29, 2016Nanjing, ChinaDrugsNo Action Indicated (NAI)3009805706
Apr 4, 2014Nanjing, ChinaDrugsVoluntary Action Indicated (VAI)3009805706

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

Recent 510(k) Clearances

K-NumberDeviceDate
K201545Surgical Face MaskFeb 12, 2021